JAPAN

Johnson & Johnson seeks COVID-19 vaccine approval in Japan

U.S. health care conglomerate Johnson & Johnson said Monday that it had filed for regulatory approval of its one-shot COVID-19 vaccine in Japan, and that it could begin supplying doses to the country in early 2022, once approval is given. | REUTERS

KYODO

May 25, 2021

U.S. pharmaceutical company Johnson & Johnson said Monday it had filed for Japanese health ministry approval of its coronavirus vaccine through its local unit.

If approved, the firm said its vaccine could be delivered to Japan in early 2022, becoming the fourth vaccine in the fight against COVID-19 in the country, which is lagging behind other nations in its vaccine rollout.

According to the unit, Janssen Pharmaceutical K.K., its early-stage study results from 250 healthy people between the ages of 20 and 55 and those aged 65 or older in Japan showed that the one-shot vaccine did not pose safety risks.

Johnson & Johnson seeks COVID-19 vaccine approval in Japan

In your social network

In your inbox

In your social network

In your inbox